Scopolamine - Revision history

Danbot: Add Indications by Condition SMW query table

2026-03-20T17:46:01Z

Add Indications by Condition SMW query table

← Revisión anterior		Revisión del 17:46 20 mar 2026
Línea 54:		Línea 54:
	==Comments==		==Comments==



			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Scopolamine]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|mainlabel=-
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

ClaireLewis: /* Administration */

2017-07-12T19:14:23Z

Administration

← Revisión anterior		Revisión del 19:14 12 jul 2017
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: [[Anticholinergics]]		*Type: [[Anticholinergics]], [[Cycloplegic]]
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic		*Routes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic
	*Common Trade Names:		*Common Trade Names:

	==Adult Dosing==		==Adult Dosing==

ClaireLewis: Created page with "==Administration== Type: Anticholinergics Dosage Forms: Routes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic Common Trade..."

2017-04-03T15:12:10Z

Created page with "==Administration== *Type: Anticholinergics *Dosage Forms: *Routes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic *Common Trade..."

Página nueva

==Administration==
*Type: [[Anticholinergics]]
*Dosage Forms:
*Routes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic
*Common Trade Names:

==Adult Dosing==
*0.32-0.1mg IV/IM/SubQ
*0.4-0.8mg PO
*1-2 drops (0.25% ophthalmic solution) up to 4 times daily
*1 transdermal patch q72h (each 1.5mg patch delivers 1mg scopolamine over 72h)

==Pediatric Dosing==
*Sedation:
**6mo-3y: 0.1-0.15 mg IM/IV/subQ
**3-6y: 0.2-0.3 mg IM/IV/subQ
*Vomiting: 6 mcg/kg subQ
*Transdermal patch not FDA-approved for children

==Special Populations==
*[[Drug pregnancy categories|Pregnancy Rating]]: C
*Lactation risk: infant risk is minimal
*Renal dosing: contraindicated in renal impairment
*Hepatic dosing: contraindicated in hepatic impairment

==Contraindications==
*Allergy to class/drug
*Glaucoma
*Chronic lung disease (repeated doses)
*Prostatic hypertrophy
*Pyloric obstruction

==Adverse Reactions==
===Serious===
*Tachyarrhythmia
*Hallucinations, confusion
*Glaucoma
*Systemic absorption of ophthalmic formulation
===Common===
*Dry skin, diminished sweating
*Xerostomia
*Amnesia, somnolence
*Mydriasis, blurred vision
*Local irritation

==Pharmacology==
*Half-life: 9.5h (transdermal)
*Metabolism:
*Excretion:

==Mechanism of Action==
*Belladonna alkaloid with anticholinergic (predominantly antimuscarinic) properties

==Comments==

==See Also==
*[[Anticholinergic toxicity]]

==References==
<references/>

[[Category:Pharmacology]]

Scopolamine - Revision history

Danbot: Add Indications by Condition SMW query table

ClaireLewis: /* Administration */

ClaireLewis: Created page with "==Administration== *Type: Anticholinergics *Dosage Forms: *Routes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic *Common Trade..."

ClaireLewis: Created page with "==Administration== Type: Anticholinergics Dosage Forms: Routes of Administration: scopolamine- transdermal. Scopolamine hydrobromide- IV, oral, Ophthalmic Common Trade..."